[go: up one dir, main page]

DK0767172T3 - 8-arylalkyl and 8-arylheteroalkyl-5,11-dihydro-6H-dipyrido [3,2-b: 2 ', 3'-e] [1,4] diazepines and their use in the prevention or treatment of HIV infection - Google Patents

8-arylalkyl and 8-arylheteroalkyl-5,11-dihydro-6H-dipyrido [3,2-b: 2 ', 3'-e] [1,4] diazepines and their use in the prevention or treatment of HIV infection

Info

Publication number
DK0767172T3
DK0767172T3 DK96115901T DK96115901T DK0767172T3 DK 0767172 T3 DK0767172 T3 DK 0767172T3 DK 96115901 T DK96115901 T DK 96115901T DK 96115901 T DK96115901 T DK 96115901T DK 0767172 T3 DK0767172 T3 DK 0767172T3
Authority
DK
Denmark
Prior art keywords
arylalkyl
dihydro
prevention
treatment
hiv infection
Prior art date
Application number
DK96115901T
Other languages
Danish (da)
Inventor
Charles L Cywin
Maryann Hoermann
Janice M Klunder
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK0767172T3 publication Critical patent/DK0767172T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B57/00—Other synthetic dyes of known constitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The invention relates to novel 8-arylalkyl-5,11-dihydro-6H-dipyridoÄ3,2-b:2',3'-eÜÄ1,4Üdiazepines of general formula 1 <CHEM> which are useful in the prevention or treatment of HIV infection.
DK96115901T 1995-10-06 1996-10-04 8-arylalkyl and 8-arylheteroalkyl-5,11-dihydro-6H-dipyrido [3,2-b: 2 ', 3'-e] [1,4] diazepines and their use in the prevention or treatment of HIV infection DK0767172T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US480695P 1995-10-06 1995-10-06
US869595P 1995-12-15 1995-12-15

Publications (1)

Publication Number Publication Date
DK0767172T3 true DK0767172T3 (en) 2003-07-21

Family

ID=26673503

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96115901T DK0767172T3 (en) 1995-10-06 1996-10-04 8-arylalkyl and 8-arylheteroalkyl-5,11-dihydro-6H-dipyrido [3,2-b: 2 ', 3'-e] [1,4] diazepines and their use in the prevention or treatment of HIV infection

Country Status (8)

Country Link
US (1) US5705499A (en)
EP (1) EP0767172B1 (en)
JP (1) JPH09188680A (en)
AT (1) ATE235495T1 (en)
DE (1) DE69626915T2 (en)
DK (1) DK0767172T3 (en)
ES (1) ES2191075T3 (en)
PT (1) PT767172E (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747488A (en) * 1996-01-30 1998-05-05 Boehringer Ingelheim Pharmaceuticals, Inc. 2-aryl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-E! 1, 4!diazepines and their use in the treatment of HIV infection
GB9715584D0 (en) * 1997-07-23 1997-10-01 Eisai Co Ltd Compounds
UA71971C2 (en) 1999-06-04 2005-01-17 Agoron Pharmaceuticals Inc Diaminothiazoles, composition based thereon, a method for modulation of protein kinases activity, a method for the treatment of diseases mediated by protein kinases
US6455554B1 (en) 1999-06-07 2002-09-24 Targacept, Inc. Oxopyridinyl pharmaceutical compositions and methods for use
TWI262914B (en) 1999-07-02 2006-10-01 Agouron Pharma Compounds and pharmaceutical compositions for inhibiting protein kinases
US7141581B2 (en) * 1999-07-02 2006-11-28 Agouron Pharmaceuticals, Inc. Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
HN2001000008A (en) 2000-01-21 2003-12-11 Inc Agouron Pharmaceuticals AMIDA COMPOSITE AND PHARMACEUTICAL COMPOSITIONS TO INHIBIT PROTEINKINASES, AND THE INSTRUCTIONS FOR USE
WO2001079198A1 (en) 2000-04-18 2001-10-25 Agouron Pharmaceuticals, Inc. Pyrazoles for inhibiting protein kinase
SI1294720T1 (en) * 2000-06-16 2006-08-31 Boehringer Ingelheim Ca Ltd Non-nucleoside reverse transcriptase inhibitors
TWI270547B (en) * 2000-06-16 2007-01-11 Boehringer Ingelheim Ca Ltd Non-nucleoside reverse transcriptase inhibitors
US6716836B2 (en) 2001-03-22 2004-04-06 Boehringer Ingelheim (Canada) Ltd. Non-nucleoside reverse transcriptase inhibitors
US6673791B2 (en) * 2001-07-30 2004-01-06 Boehringer Ingelheim (Canada) Ltd. Non-nucleoside reverse transcriptase inhibitors
US6706706B2 (en) * 2002-03-27 2004-03-16 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors
US6806265B2 (en) * 2002-05-16 2004-10-19 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors
CA2495744A1 (en) 2002-09-19 2004-04-01 Boehringer Ingelheim (Canada) Ltd. Non-nucleoside reverse transcriptase inhibitors
EP1554276B1 (en) * 2002-09-19 2006-06-28 Boehringer Ingelheim (Canada) Ltd. Non-nucleoside reverse transcriptase inhibitors
AU2003291310A1 (en) 2002-11-06 2004-06-03 Bristol-Myers Squibb Company Fused heterocyclic compounds and use thereof
WO2004087140A1 (en) * 2003-03-27 2004-10-14 Boehringer Ingelheim International Gmbh Antiviral combination of a dipyridodiazepinone and a further antiretroviral compound
CA2560346A1 (en) * 2004-04-13 2005-10-27 Icagen, Inc. Polycyclic pyridines as potassium ion channel modulators
JP5064216B2 (en) 2004-07-16 2012-10-31 プロテオシス・アーゲー Muscarinic antagonists having PARP and SIR modulating activity as therapeutic agents for inflammatory diseases
WO2010081823A1 (en) 2009-01-13 2010-07-22 Proteosys Ag Pirenzepine as otoprotective agent
JP2017535573A (en) 2014-11-25 2017-11-30 バイエル ファーマ アクチエンゲゼルシャフト Substituted pyridobenzodiazepinone derivatives and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366972A (en) * 1989-04-20 1994-11-22 Boehringer Ingelheim Pharmaceuticals, Inc. 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
WO1995022545A1 (en) * 1994-02-18 1995-08-24 Boehringer Ingelheim Pharmaceuticals, Inc. 2-HETEROARYL-5,11-DIHYDRO-6H-DIPYRIDO[3,2-b:2',3'-e][1,4]DIAZEPINES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION

Also Published As

Publication number Publication date
ATE235495T1 (en) 2003-04-15
DE69626915D1 (en) 2003-04-30
ES2191075T3 (en) 2003-09-01
PT767172E (en) 2003-08-29
DE69626915T2 (en) 2003-11-13
EP0767172B1 (en) 2003-03-26
EP0767172A1 (en) 1997-04-09
JPH09188680A (en) 1997-07-22
US5705499A (en) 1998-01-06

Similar Documents

Publication Publication Date Title
DK0767172T3 (en) 8-arylalkyl and 8-arylheteroalkyl-5,11-dihydro-6H-dipyrido [3,2-b: 2 &#39;, 3&#39;-e] [1,4] diazepines and their use in the prevention or treatment of HIV infection
DK0429987T3 (en) 5,11-Dihydro-6H-dipyrido [3,2-b: 2 &#39;, 3&#39;-e] [1,4] diazepines and their use in the prevention or treatment of HIV infection
FI955315L (en) HIV protease inhibitors useful in the treatment of AIDS
DE69909756D1 (en) ANTIVIRAL PYRIMIDINE DERIVATIVES
ATE295355T1 (en) TRIS-SUBSTITUTED 1,3,5-TRIAZINE DERIVATIVES FOR THE TREATMENT OF HIV INFECTIONS
NO20000185D0 (en) Condensed 1,2,4-thiadiazine derivatives, their preparation and use
FI952302L (en) Pyran-2-ones and 5,6-dihydropyranones useful in the treatment of HIV and other retroviruses
PT842934E (en) 5-HT1F AGONISTS
DK0410148T3 (en) Novel 5,11-dihydro-6H-dipyrido (3,2-b: 2,3-e) - (1,4) diazepin-6-ones and thiones and their use in the prevention or treatment of AIDS
DK0604183T3 (en) HIV protease inhibitors useful in the treatment of AIDS
ES2162110T3 (en) DERIVATIVES OF ANTIMALARY QUINOLINE.
EP0347852A3 (en) Novel neplanocin derivatives
CA2014885A1 (en) 6,11-dihydro-5h-pyrido[2,3-b][1,5]benzodiazepin-5-ones and thiones and their use in the prevention or treatment of aids
DK0916670T3 (en) Pyrrolo [3,2-b] pyridines and their use as 5-HT1f agonists
TW327171B (en) 2-heteroaryl-5 for prevention or treatment of HIV infection
EE03514B1 (en) A combination of compounds for the treatment of HIV infection or AIDS, its use and a pharmaceutical composition
MA25501A1 (en) TREATMENT OF ENDOMETRIOSIS OR STERILITY OR IMPROVEMENT OF FERTILITY.
NO934633D0 (en) Condensed heterocyclic compounds, their preparation and use
DK0393530T3 (en) 5,11-Dihydro-6H-pyrido (2,3-b) (1,4) benzodiazepine-6-ones and thiones and their use in the prevention or treatment of AIDS
FI911533A7 (en) Benzoxazine derivatives, process for their preparation and their use for the treatment or prevention of diseases
NO965591D0 (en) Combination treatment of HIV infection
PT889044E (en) DERIVATIVES OF 5- (HETEROARIL) ALTAL-3-OXO-PYRID- (1,2-A) BENZIMIDAZOLE-4-CARBOXAMIDE (GDP) USEFUL IN TREATING PERTURBACTIONS OF THE CENTRAL NERVOUS SYSTEM
NO960551D0 (en) Antibody based treatment of HIV infection
MX9604346A (en) 8-ARYLALKYL-AND 8-ARYKHETEROALKYL-5.11-DIHYDRO-6H-DIPYRIDO(3.2-b;2&#39;3&#39;-e) (1,4IDIAZEPINES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION.
DK0412941T3 (en) Phospholipids for the treatment of disseminated sclerosis